Selected Pilates training on lipid profile, fasting blood sugar, blood pressure and fat percentage of women with non-alcoholic fatty liver disease
Not Applicable
Completed
- Conditions
- on-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classified. (Nonalcoholic fatty liver disease [NAFLD])K76.0
- Registration Number
- IRCT20230216057435N2
- Lead Sponsor
- Shahid Chamran University of Ahvaz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Women with non-alcoholic fatty liver disease
Age range from 30 to 55 years
Not suffering from cardiovascular, joint and skeletal diseases
Not performing regular sports activities during the last 6 months
Exclusion Criteria
Taking supplements or lipid-lowering medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid profile. Timepoint: 24hours before and 48 hours after the end of the protocol. Method of measurement: Laboratory test kits.;Fasting blood sugar. Timepoint: 24hours before and 48 hours after the end of the protocol. Method of measurement: Laboratory test kits.;Blood pressure. Timepoint: 24hours before and 48 hours after the end of the protocol. Method of measurement: Automatic Blood Pressure.;Fat percentage. Timepoint: 24hours before and 48 hours after the end of the protocol. Method of measurement: Harpenden calipers.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link Pilates training to improvements in lipid profiles and NAFLD progression?
How does selected Pilates training compare to standard-of-care lifestyle interventions for NAFLD patients in terms of metabolic outcomes?
Are there specific biomarkers that correlate with changes in blood pressure and fat percentage during Pilates-based interventions for NAFLD?
What adverse events are associated with Pilates training in NAFLD populations and how do they compare to other non-pharmacological therapies?
How might Pilates training synergize with pharmacological treatments like GLP-1 receptor agonists for managing NAFLD-related metabolic parameters?